← Back to front page
Europe · Wires & real time · Reuters Technology

Lilly signs cancer research deal with Stipple Bio worth up to $5.9 billion

Published by Reuters Technology · United Kingdom 15 h ago
Lilly signs cancer research deal with Stipple Bio worth up to $5.9 billion
Reuters Technology

Detailed summary

Drugmaker Eli Lilly has signed an oncology research collaboration and licensing agreement worth ​up to $5.9 billion with Stipple Bio, the privately ‌held biotech firm said on…

Read the full article on Reuters Technology Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading